March 9 (Reuters) - Eli Lilly said on Monday a small number of basic Medicare drug plans may not follow the $50 per month cap on out-of-pocket costs for its weight-loss drugs, after the Medicare ...

Drug pricing, competition, and characteristics were associated with health plan restrictions, but rebates were not. Higher net prices of the drugs were associated with an increased likelihood of ...

GLP-1 drugs like Ozempic have long helped people eat less — now, they’re showing promise in helping people crave less. A new analysis of records from over 600,000 diabetic veterans found that GLP-1 ...

Feb 11 (Reuters) - Viking Therapeutics (VKTX.O), opens new tab said on Wednesday it plans to test its experimental oral obesity drug in a late-stage study later this year. Shares of the company rose ...

The FDA will drop its longtime two-study standard for the drug approval process - making it a one study rule. Dozens of Democrats to boycott Trump's State of the Union address Why no one is winning ...

A federal organization has recommended that a recently approved Alzheimer's drug should not be publicly covered. Doctors say this move misses the mark for patients who could benefit from treatment, ...

WASHINGTON — The head of the Food and Drug Administration plans to start offering bonus payments to agency drug reviewers who complete their work ahead of schedule, the latest in a flurry of changes ...

John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. WASHINGTON — The pharmaceutical ...